HqO Raises Over $50M in Series D Funding to Revolutionize the Real Estate Landscape
Along with new capital, company leverages real estate experience insights from 1.7+ million people and 8,000+ workplaces to launch the REX Platform
BOSTON, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Addressing the secular shift in how, where, and when people interact with their professional and personal environments, HqO, the world’s leading real estate experience platform, announced today it has raised over $50 million in Series D funding to fuel the company’s mission to disrupt the real estate industry. The funding round was led by Koch Real Estate Investments, a subsidiary of Koch Industries, along with participation from many of the company’s existing investors, leading venture capital and commercial real estate firms including Accomplice, Insight Partners, and Related. The additional capital brings the company’s total funding to over $200 million, bolstering an already strong balance sheet and positioning the company to continue executing on its targeted M&A strategy.
“As the real estate industry continues to radically evolve, we firmly believe that its future lies in the convergence of innovative technology, data, and customer-centric experiences. By developing cutting-edge technology and tools that prioritize user sentiment, HqO is not only adapting to the rapidly changing real estate industry, but driving its progression. With HqO’s vision and our investment, we are confident that together we are building a more transformative ecosystem,” said Justin Wilson, Managing Director at Koch Real Estate Investments, who is also joining HqO’s Board of Directors.
There has been a fundamental evolution in the real estate economy as space has moved from a required commodity to a service, and now to an experience. This is being driven by a confluence of factors, most notably the shift in the way work and life now commingle. As a result, real estate not only needs to be more flexible to meet the needs of end-users, but it must also connect with them through experience. In response, HqO has created a new market category, the Real Estate Experience (REX), putting the customer and their experiences of space at the center of this significant market transformation for the first time.
In addition, HqO is continuing to scale and innovate its customer-centric product offerings with the launch of the HqO REX Platform, the first end-to-end experience solution built around the customer. HqO’s REX Platform answers many pain points across the real estate ecosystem for owners, operators, and occupiers alike. Through a suite of powerful applications and services, the REX Platform is the single source of truth for a property, assessing the health and performance of a customer's experience within it while providing the tools to manage and optimize it, all from one central location. This is proven to boost tenant and employee retention while increasing net operating income and driving efficiencies in operating costs.
“The world has dramatically changed over the last few years, especially the way we work, live, and interact with our surroundings. In this environment of digital disruption, data, technology, and a focus on the customer are not just options; they’re mission-critical to compete,” said Chase Garbarino, Co-Founder and CEO at HqO. “HqO is here to reimagine the status quo and lead the charge toward a more connected, efficient, and user-centric real estate experience. We’re doubling down on our commitment to connect real estate to the people and help create spaces that truly serve the evolving needs of those who use them.”
Building on the success of HqO’s existing real estate experience product, now called Experience Manager (XM), which has powered over 400 million square feet around the world, Intelligence is the newest and most disruptive product within the REX Platform. Intelligence is the first and only industry standard for measuring and assessing the health and performance of a customer’s experience within a property. Through this revolutionary offering, users are able to gain immediate access to global real estate insights from more than 1.7 million employees and over 8,000 workplaces, collected through the proven methodology of Leesman, an HqO company and the industry’s most trusted workplace experience data source and benchmarking framework. Additionally, users can gather property-specific insights by deploying Intelligence at their properties.
The Intelligence suite of products includes:
- The REX Assessment—The industry-leading tool for quantifying employees’ workstyles, preferences, and overall satisfaction within a physical space
- The REX Score—The quantified value operators and occupiers get from a building using data from the REX Assessment to show the success of customers’ experiences at a property, which directly correlates to how likely a property is to achieve high occupancy, attract and retain tenants, and generate revenue
- The REX Index—The industry’s first global real estate user experience indicator, benchmark, and tool for certifying and exploring properties through the lens of people’s experiences, ranking the landlords and occupiers with leading REX Scores
HqO’s REX Platform also includes Marketplace, an exclusive ecosystem built for HqO’s customers, both operators and occupiers, to help deliver optimal experiences for end-users of real estate by providing access to and integration with a growing directory of the most impactful and desired services and amenity partners.
HqO’s REX Platform has already connected over 350,000 users to real estate across 700 properties in over 32 countries. It has helped owners, operators, and occupiers to better understand and engage with tenants and employees while meeting their people and business goals. HqO services real estate clients worldwide, including Related, Vornado Realty Trust, Nuveen Real Estate, Jamestown L.P., Hudson Pacific Properties, Grosvenor, Legal & General Investment Managers, J.P. Morgan Asset Management, Hines, abrdn, LaSalle, Primonial, ARC and Chiswick Park.
HqO is leading the transformation of the way people experience real estate by converging data, technology, and the customer. Through its Real Estate Experience (REX) Platform—a powerful and dynamic suite of applications and services—HqO has powered over 400 million square feet at over 700 properties across 32 countries. The world’s most innovative organizations rely on HqO to drive operational excellence by maximizing and boosting tenant and employee acquisition, retention, and engagement.
For more information, visit www.hqo.com.
For additional questions or more information, please reach out to HqOPR@boathouseinc.comTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Managers’ transactions9.12.2023 18:12:40 CET | Press release
December 9, 2023 Announcement no. 21 Managers’ transactions COPENHAGEN, DENMARK and BOSTON, MA, December 9, 2023, (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or the Company) (CPH:BIOPOR), has received notice pursuant to article 19 of Regulation (EU) no. 596/2014 of the below transaction related to shares in BioPorto made by persons discharging managerial responsibilities in BioPorto and/or persons closely related with them. 1. Details of the person discharging managerial responsibilities/person closely associated a) Name Singer Asefzadeh Family Holding Trust 2. Reason for the notification a) Position/status Closely associated person to Michael S. Singer, member of the Board of Directors of BioPorto A/S b) Initial notification/amendment Initial notification 3. Details of the issuer a) Name BioPorto A/S b) LEI 5299004SWFL5JAN4W830 4. Details of the transaction(s) a) Description of the financial instrument type of instrument and Identification code Shares, ISIN code DK0011048619 b) Nature o
New Pivotal Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Demonstrates High Overall and Complete Responses in Patients with Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL)9.12.2023 18:00:00 CET | Press release
Media Release COPENHAGEN, Denmark; December 9, 2023 Data from the pivotal phase 1/2 EPCORE™ NHL-1 study showed 82 percent overall response rate (ORR), 63 percent complete response (CR) and 67 percent minimal residual disease (MRD) negativity in patients with relapsed/refractory (R/R) follicular lymphoma (FL) treated with subcutaneous epcoritamab Results presented at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition include data from an optimized step-up dosing schedule for FL patients showing meaningful reduction in risk and severity of cytokine release syndrome (CRS) Follicular lymphoma is the second most common form of non-Hodgkin’s lymphoma, is considered incurable and can be difficult to treat in the R/R setting Genmab A/S (Nasdaq: GMAB) and AbbVie (NYSE: ABBV) todayannounced new data from the ongoing phase 1/2 EPCORE™ NHL-1 clinical trial investigating epcoritamab (DuoBody® CD3xCD20), a T-cell engaging bispecific antibody administered subcutaneously, demo
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG51019.12.2023 18:00:00 CET | Press release
Additional safety and efficacy data further support potential of innovative, decentralized approach to CAR-T manufacturing and transformational impact on patients with severe hematologic cancersTwo poster presentations include recent data updates and additional data not included in the ASH abstracts Galapagos to host a Key Opinion Leader (KOL) event with live webcast on Sunday, 10 December 2023 at 11:00 am PT/20:00 CET Mechelen, Belgium; 9 December 2023, 18:00 CET; Galapagos NV (Euronext & NASDAQ: GLPG) topresent additional encouraging clinical data from the ongoing Phase 1/2 CD19 CAR-T studies, EUPLAGIA-1 with GLPG5201 and ATALANTA-1 with GLPG5101, in patients with relapsed/refractory chronic lymphocytic leukemia (rrCLL), with or without Richter transformation, and non-Hodgkin lymphoma (rrNHL), during two poster sessions at the 65th American Society of Hematology (ASH) Annual Meeting taking place in San Diego, from 9-12 December. “We are very pleased to share promising new data from o
New data reinforce the benefit of early preventative treatment with Roche’s Hemlibra for babies with severe haemophilia A9.12.2023 17:30:00 CET | Press release
Phase III HAVEN 7 primary data presented at ASH 2023 provide additional confidence in the favourable efficacy and safety profile of subcutaneous Hemlibra given soon after birth 1At nearly two years median follow-up in the descriptive, single-arm study, no babies experienced spontaneous bleeds requiring treatment, and all treated bleeds were as a result of trauma 1Safety results were consistent with previous studies of Hemlibra, with no new safety signals observed 1The HAVEN 7 study was developed in collaboration with the haemophilia A community, to generate additional evidence for the prophylactic treatment of infants with haemophilia A Basel, 09 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the primary analysis of the Phase III HAVEN 7 study reinforced the efficacy and safety of Hemlibra® (emicizumab) in previously untreated or minimally treated infants with severe haemophilia A without factor VIII inhibitors. Results showed that Hemlibra achieved meaningful
Bulletin from Annual General Meeting in SkiStar AB9.12.2023 16:00:00 CET | Press release
At SkiStar AB (publ)’s annual general meeting, held in Sälen on 9 December 2023, the following decisions were made. A dividend of SEK 2.60 per share was adopted. Record day 12 December 2023.Lena Apler, Fredrik Paulsson, Gunilla Rudebjer, Anders Sundström, Anders Svensson and Vegard Søraunet were re-elected to the board and Carina Åkerström was elected as new board member.Anders Sundström was re-elected chairman of the board.Board fees, including committee fees, were raised to a total of SEK 2,890,000 (2022: SEK 2,810,000). The fees shall be distributed as follows: SEK 670,000 (650,000) to the chairman of the board and SEK 310,000 (300,000) each to the other non-executive directors. Audit committee members will receive total fees of SEK 240,000 (unchanged), distributed as follows: SEK 120,000 to the committee chairman and SEK 60,000 to each of the other two members. Remuneration committee members will receive total fees of SEK 120,000 (unchanged), distributed as follows: SEK 60,000 to t